Blood-grouping reagents

Tender description

NHSBT intends to undertake an OJEU tender exercise for a managed service contract for the supply of secondary blood grouping and sickle cell screening systems. This must be fully automated as a secondary testing technology, for ABO and Rh D typing, antibody screening, extended red cell phenotyping and HbAS (heterozygous sickle cell trait) screening for donor blood samples. See the tender documentation for the full list of mandatory tests required. The managed service contract duration is for 5 years with the option to extend for 2 periods of 12 months. A complete solution (test system/s) includes all necessary maintenance, consumables, software and overall support required to carry out the test and comply with required MHRA regulations by having a ‘CE’ mark. See the tender documentation for the full list of mandatory tests required. The managed service contract duration is for 5 years with the option to extend for 2 periods of 12 months.